Page last updated: 2024-09-03

pyroglutamyl-histidyl-glycine and Anorexia

pyroglutamyl-histidyl-glycine has been researched along with Anorexia in 1 studies

*Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bi, P; Chen, S; Dai, Y; Li, Y; Nie, K; Zhang, G1

Other Studies

1 other study(ies) available for pyroglutamyl-histidyl-glycine and Anorexia

ArticleYear
Liujunzi Decoction ameliorated cisplatin-induced anorexia by inhibiting the JAK-STAT signaling pathway and coordinating anorexigenic and orexigenic neuropeptides in rats.
    Journal of ethnopharmacology, 2022, Mar-01, Volume: 285

    Topics: Animals; Anorexia; Antineoplastic Agents; Cisplatin; Drugs, Chinese Herbal; Gene Expression Regulation; Janus Kinases; Male; Molecular Docking Simulation; Network Pharmacology; Neuropeptides; Oligopeptides; Phytotherapy; Pyrrolidonecarboxylic Acid; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT Transcription Factors

2022